Platform Strategy and
Data-driven development
in Pharmaceutical Industry
Lukas Ott - Domain Architect R&D
ITU - Guest Lecture - 8 april 2022
Agenda
1. Pharmaceutical Research & Development 101
2. From Enterprise Architecture to platform strategy execution
3. Discussion on use cases development for data analytics
Pharmaceutical Development in a Nutshell
Pharmaceuticals
Small
Molecule
(Chemical)
Large
Molecule
(Biologics)
The core of R&D in Drug Development
Target
Identification
Drug
Discovery
From discovery to approved product
From Enterprise Architecture to
Technical Architecture
Source: https://www.leanix.net/en/wiki/ea/enterprise-architect-vs-solution-architect-vs-technical-architect-whats-the-difference#form
IT portfolio is a balance between operative and
strategic development
IT Portfolio Management
Architecture review is a key milestone of the
analysis phase of projects
Key architectural principles
1. Business
2. Application
3. Information
4. Technology
5. Security & Compliance / Data Privacy
Core functionalities of a system in an enterprise
Data
Documents
Workflow
Business Process
Application /
Platform
Global Platform Strategy as Foundation
Adopt before Adapt
“A platform strategy is the mobilization of a networked business
platform to expand into and operate in a given domain. A business
platform, in turn, is a nexus of rules and infrastructure that facilitate
interactions among network users.”
In R&D Domain that means that the goal is to build foundational
platform that are supporting the business processes end-to-end.
R&D Domain - Background
● Use the right datasets - data quality is key!
● Regulatory Authorities
● Content Accumulation
● Leverage Available Content
● Know who does what
Use cases in Pharma
Simplify Compliance
● Detect relevant information in
regulatory texts
● Push information to the right
expert
Optimize Clinical Trials
● Make evidence-based decisions
based on all clinical trial data
available
Stay on Top of Research Trends
● Provides access to the latest
scientific information
Accelerate Time to Market
● Speeds up new drug application
submission
● Reduces costs for new drug
development
Connect to External Experts
● Connect to relevant experts
within external research
organizations
● Identify the most promising
collaboration partners
Connect Experts & Expertise
Internally
● Reveals networks of experts
Natural Language Processing (NLP) /
Machine Learning (ML) Use Cases
1. Business case
a. Create data stories
b. Main concepts
2. Build data pipelines
a. Prerequisites
b. Indexing data
c. Create service & label data
Questions & Open Discussion
Sources
https://de.slideshare.net/LukasOtt/
https://www.leanix.net/en/wiki/ea/enterprise-architect-vs-solution-architect-vs-technical-
architect-whats-the-difference#form
https://towardsdatascience.com/data-driven-isnt-dead-3230378e4c7a
From discovery to approved product
Platform Strategy and Data-driven development in Pharmaceutical Industry
Platform Strategy and Data-driven development in Pharmaceutical Industry
Platform Strategy and Data-driven development in Pharmaceutical Industry

Platform Strategy and Data-driven development in Pharmaceutical Industry

Editor's Notes

  • #11 Business Redesign lean processes by leveraging existing ones and following industry standards Invest in differentiating capabilities Application Prefer reuse over buy over build. Standard solution, minimal configuration, no customisation Ensure good end-user experience (performance, availability, usability) Information Data is uniquely identified and traceable through the processes, applications and life cycle Ensure data integrity, availability and accessibility (anywhere, anytime) Technology Design for interoperability, reusability and scalability Cloud first Security & Compliance / Security & Privacy Security by design Always compliant -> Privacy by design Data minimization
  • #15 Use the right datasets Clinical trials generating huge amount of contents Regulatory Authorities Following publications Making sure submission fulfill requirements ContenUse the right datasets Clinical trials generating huge amount of contents Regulatory Authorities Following publications Making sure submission fulfill requirements Content Accumulation Drug research Lab projects Approval processes Pharmacovigilance Leverage Available Content Deliver search & knowledge application to frontline sales teams Know who does what Select the ideal team of experts Undetected overlapping or identical projects